Patent Board Grants Inter Partes Review Of Cancer-Fighting Therapy
ALEXANDRIA, Va. — A claimed method and composition for treating cancer with hormone therapy is likely unpatentable under 35 U.S. Code Section 103, the Patent Trial and Appeal Board ruled May...To view the full article, register now.
Already a subscriber? Click here to view full article